Immunogenicity and Safety of Havrix™ Co-Administered With a Diphtheria, Tetanus and Pertussis and a Haemophilus b Vaccine in Children Aged 15 Months

NCT00197236 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

468

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis A

Interventions

BIOLOGICAL: Havrix™
BIOLOGICAL: Infanrix™
BIOLOGICAL: ActHIB™

Sponsor

GlaxoSmithKline